Chronic hyperinsulinemia, as observed in T2DM and obesity, downregulates insulin receptor expression at the blood–brain barrier (BBB), limiting insulin transport into the central nervous system and exacerbating cerebral hypoinsulinemia [74,75]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.